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An error appeared in the 1 December 2018 supplement issue 
of the journal [van Duin D, Gu P, Dong J, et al. China–United 
States Research Collaborations in Antimicrobial Resistance. 
Clin Infect Dis 2018; 67(s2):s142-s145. https://doi.org/10.1093/
cid/ciy694]. The last name of the fourth author should be “Paff ” 
[not Pfaff].
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An error appeared in the initial publication of this article 
[Mullane KM, Winston DJ, Nooka A, et  al. A  Randomized, 
Placebo-controlled Trial of Fidaxomicin for Prophylaxis of 
Clostridium difficile–associated Diarrhea in Adults Undergoing 
Hematopoietic Stem Cell Transplantation. Clin Infect Dis 
https://doi.org/10.1093/cid/ciy484]. This article was originally 
published with the following error:
Figure 2 currently appears without any lines at the top of the 
figure representing the incidence of CDAD over time for fidax-
omicin and placebo. The correct figure appears below.
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